Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSPO | P30536 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.35 |
| ▸ | PTGER4 | P35408 | 4/20 | 0.34 |
| ▸ | PPARG | P37231 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.33 |
| ▸ | EDNRA | P25101 | 1/20 | 0.32 |
| ▸ | RAC2 | P15153 | 1/20 | 0.32 |
| ▸ | RAC3 | P60763 | 1/20 | 0.32 |
| ▸ | CDC42 | P60953 | 1/20 | 0.32 |
| ▸ | RAC1 | P63000 | 1/20 | 0.32 |
| ▸ | PPARA | Q07869 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.32 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.32 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.32 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24065233 | 0.94 | KDM4E (0.38) | TSPOKDM4EATML3MBTL1HDAC4 | |
| SCHEMBL21968774 | 0.93 | KDM4E (0.37) | TSPOKDM4EATML3MBTL1HDAC4 | |
| SCHEMBL22021297 | 0.90 | KDM4E (0.39) | TSPOKDM4EATML3MBTL1HDAC4 | |
| SCHEMBL16985652 | 0.90 | KDM4E (0.33) | TSPOKDM4EATML3MBTL1PTGER4 | |
| SCHEMBL21128839 | 0.89 | TSPO (0.36) | TSPOKDM4EATML3MBTL1HDAC4 | |
| SCHEMBL18562511 | 0.89 | KDM4E (0.36) | TSPOKDM4EATML3MBTL1HDAC4 | |
| SCHEMBL21129002 | 0.89 | KDM4E (0.36) | TSPOKDM4EATML3MBTL1HDAC4 | |
| SCHEMBL21128988 | 0.88 | KDM4E (0.43) | KDM4EATML3MBTL1HDAC4PPARG | |
| SCHEMBL14767449 | 0.87 | KDM4E (0.45) | KDM4EATML3MBTL1PTGER4PPARG | |
| SCHEMBL23510398 | 0.84 | KDM4E (0.40) | KDM4EATML3MBTL1PTGER4PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024128697-A1 | COMPOSITION FOR OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | 삼성에스디아이 주식회사 | 2024-06-20 | — | — | WO | disclosed |
| US-11217756-B2 | Compound for organic optoelectronic device, composition for organic optoelectronic device and organic optoelectronic device and display device | SAMSUNG SDI CO., LTD. (KR) | 2022-01-04 | — | — | US | disclosed |
| US-20190198772-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEIVCE | SAMSUNG SDI CO., LTD. (KR) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11217756-B2 | Compound for organic optoelectronic device, composition for organic optoelectronic device and organic optoelectronic device and display device | OXER1, OCIAD1, OCIAD2 | TSPO 1621/4885KDM4E 3750/4885ATM 3847/4885 |
| US-20190198772-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEIVCE | ODC1, OR10J3, OCIAD2 | TSPO 2461/4885KDM4E 2702/4885ATM 4664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.